دورية أكاديمية

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

التفاصيل البيبلوغرافية
العنوان: Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
المؤلفون: Robert, Caroline, Ribas, Antoni, Wolchok, Jedd D, Hodi, F Stephen, Hamid, Omid, Kefford, Richard, Weber, Jeffrey S, Joshua, Anthony M, Hwu, Wen-Jen, Gangadhar, Tara C, Patnaik, Amita, Dronca, Roxana, Zarour, Hassane, Joseph, Richard W, Boasberg, Peter, Chmielowski, Bartosz, Mateus, Christine, Postow, Michael A, Gergich, Kevin, Elassaiss-Schaap, Jeroen, Li, Xiaoyun Nicole, Iannone, Robert, Ebbinghaus, Scot W, Kang, S Peter, Daud, Adil
المصدر: The Lancet ; volume 384, issue 9948, page 1109-1117 ; ISSN 0140-6736
بيانات النشر: Elsevier BV
سنة النشر: 2014
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/s0140-6736(14)60958-2
الإتاحة: https://doi.org/10.1016/s0140-6736Test(14)60958-2
https://api.elsevier.com/content/article/PII:S0140673614609582?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0140673614609582?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/
رقم الانضمام: edsbas.1C22DB95
قاعدة البيانات: BASE